publication date: Aug. 3, 2018

Conversation with The Cancer Letter AACR’s Sweeney: Adoption of data standards necessary for advancing real-world evidence in precision oncology Shawn_M_Sweeney

Shawn Sweeney

Director, AACR Project GENIE Coordinating Center

 

Researchers at Project GENIE, the largest publicly available genomic database in the U.S., understand what it takes to convert sequencing data into real-world evidence: a lot of money, manpower, and data harmonization, said Shawn Sweeney, director of the American Association for Cancer Research Project GENIE Coordinating Center.

Project GENIE’s spend on data curation adds up to $3 million out of its $5 million annual budget. The AACR cancer registry, which receives clinical-grade genomic and clinical outcomes data from 19 institutions, is on track to amass 60,000 sequenced tumors by January 2019, a rapid increase from nearly 19,000 cases within two years.

“We’re actually in a transitional phase, where we’ve secured a significant amount of funding to go on and collect a deeper amount or a more complete picture of each patient’s experience with cancer, so more clinical data—beginning with a small test set of sites and six cancers, and then expanding over the next few years to more sites and more cancers,” Sweeney … Continue reading AACR’s Sweeney: Adoption of data standards necessary for advancing real-world evidence in precision oncology

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.